Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria B Karpova

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Cancer Research and Clinical Oncology|January 18, 2006
Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjectsEvgeniya V Belogubova, Yulia M Ulibina, Irina K Suvorova, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
A novel approach for assessment of cancer predisposing roles of GSTM1 and GSTT1 genes: use of putatively cancer resistant elderly tumor-free smokers as the referentsEvgeniya V Belogubova, Alexandr V Togo, Maria B Karpova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
MEK1 mutations confer resistance to MEK and B-RAF inhibitionCaroline M Emery, Krishna G Vijayendran, Marie C Zipser, et al.
Blood|January 7, 2011
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascadeMichael K Kiessling, Patrick A Oberholzer, Chandrani Mondal, et al.
The Journal of Investigative Dermatology|September 18, 2009
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoidesRocío Salgado, Octavio Servitje, Fernando Gallardo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Cancer Research and Clinical Oncology|January 18, 2006
Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjectsEvgeniya V Belogubova, Yulia M Ulibina, Irina K Suvorova, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
A novel approach for assessment of cancer predisposing roles of GSTM1 and GSTT1 genes: use of putatively cancer resistant elderly tumor-free smokers as the referentsEvgeniya V Belogubova, Alexandr V Togo, Maria B Karpova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
MEK1 mutations confer resistance to MEK and B-RAF inhibitionCaroline M Emery, Krishna G Vijayendran, Marie C Zipser, et al.
Blood|January 7, 2011
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascadeMichael K Kiessling, Patrick A Oberholzer, Chandrani Mondal, et al.
The Journal of Investigative Dermatology|September 18, 2009
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoidesRocío Salgado, Octavio Servitje, Fernando Gallardo, et al.
Pageof 2